Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
Pasadena sues UCLA over potential move of home football games from the Rose Bowl to SoFi Stadium, citing breach of long-term lease and over $150 million in taxpayer-funded renovations.
Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
Pasadena sues UCLA over potential move of home football games from the Rose Bowl to SoFi Stadium, citing breach of long-term lease and over $150 million in taxpayer-funded renovations.